Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
respiratory complications are very prevalent in children with beta thalasemia major (BTM), so choosing inspiratory muscle trianing to decrease of prevent it and to improve pulmoanry funntions is important
children patients with BTM accounted 40 children will assigned to a group of inspiratory muscle training or waiting list group. the group will contain twenty children. the group of training will receive two session per day of training by threshold inspiratory muscle trainer ( for six day per week for 12 weeks)
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| study group | Experimental | children patients with BTM accounted 20 children will receive two session per day of training by threshold inspiratory muscle trainer ( for six day per week for 12 weeks). the session will contain six sets of inspiratory muscle training and the one set will contain five respiratory cycles |
|
| control group | No Intervention | children patients with BTM accounted 20 children will receive no trianiing and will serve as control children group |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| inspiratory muscle training | Behavioral | children patients with BTM accounted 20 children will receive two session per day of training by threshold inspiratory muscle trainer ( for six day per week for 12 weeks). the session will contain six sets of inspiratory muscle training and the one set will contain five respiratory cycles |
| Measure | Description | Time Frame |
|---|---|---|
| forced expiratory volume t the first second of expiration | it will measure pulmonary function | it will be assessed after 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| forced vital capcity | it will measure pulmonary function | it will be assessed after 12 weeks |
| FEV1/FVC | it will measure pulmonary function |
Not provided
Inclusion Criteria:
Exclusion Criteria:
self-representation of gender birth-certificate identity.
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| hagar el-hadidy, lecturer | Contact | 020100 745 3552 | hagarhadidy2016@gmail.com | |
| Shimaa Boundok, lectuerer | Contact | 01223749627 | dr.shaimaa.bondok@dtu.edu.eg |
| Name | Affiliation | Role |
|---|---|---|
| hagar el-hadidy, lecturer | Faculty of Physical Therapy, Ahram Canadian University (ACU), Giza, Egypt | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ahram canadian university | Recruiting | Giza | Egypt |
Not provided
| ID | Term |
|---|---|
| D017086 | beta-Thalassemia |
| ID | Term |
|---|---|
| D013789 | Thalassemia |
| D000745 | Anemia, Hemolytic, Congenital |
| D000743 | Anemia, Hemolytic |
| D000740 | Anemia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| it will be assessed after 12 weeks |
| maximal inspiratory pressure | it will measure strength of inspiratory muscles | it will be assessed after 12 weeks |
| six minute walk testing | it will measure aerobic capacity | it will be assessed after 12 weeks |
| Pediatrics' Quality of Life Inventory (children proxy) | it will assess quality of life and filled by children | it will be assessed after 12 weeks |
| Pediatrics' Quality of Life Inventory (parent proxy) | it will assess quality of life and filled by parents of children | it will be assessed after 12 weeks |
| D006402 |
| Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D006453 | Hemoglobinopathies |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |